We are live on ! Find out more
OSIR

Osiris Therapeutics, Inc. Common Stock
OSIR

Delisted

OSIR was delisted on the 16th of April, 2019.

68 hedge funds and large institutions have $36.2M invested in Osiris Therapeutics, Inc. Common Stock in 2016 Q2 according to their latest regulatory filings, with 8 funds opening new positions, 22 increasing their positions, 17 reducing their positions, and 18 closing their positions.

New
Increased
Maintained
Reduced
Closed

29% more repeat investments, than reductions

Existing positions increased: 22 | Existing positions reduced: 17

23% more call options, than puts

Call options by funds: $311K | Put options by funds: $253K

11% less capital invested

Capital invested by funds: $41M → $36.2M (-$4.7M)

15% less funds holding

Funds holding: 8068 (-12)

56% less first-time investments, than exits

New positions opened: 8 | Existing positions closed: 18

Holders
68
Holders Change
-12
Holders Change %
-15%
% of All Funds
1.81%
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
8
Increased
22
Reduced
17
Closed
18
Calls
$311K
Puts
$253K
Net Calls
+$58K
Net Calls Change
+$1M
Name Holding Trade Value Shares
Change
Change in
Stake
Janney Montgomery Scott
76
Janney Montgomery Scott
Pennsylvania
-$71K -12,357 Closed
AIM
77
Alambic Investment Management
California
-$59K -10,400 Closed
CG
78
Cutler Group
California
-$49K -9,100 Closed
Simplex Trading
79
Simplex Trading
Illinois
-$36.2K -6,725 Closed
RA
80
Rational Advisors
New York
-$29K -5,000 Closed
BG
81
BlackRock Group
United Kingdom
-$26K -4,695 Closed
Teacher Retirement System of Texas
82
Teacher Retirement System of Texas
Texas
-$12K -2,114 Closed
Zurich Cantonal Bank
83
Zurich Cantonal Bank
Switzerland
-$4K -729 Closed
AG
84
Advisor Group
Arizona
+$538 +100 New

OSIR Hedge Fund Activity: Q2 2016 in Review

68 of the 3,748 institutional investors tracked by Wall St. Rank reported a position in Osiris Therapeutics, Inc. Common Stock (OSIR) for Q2 2016, worth a combined $36.2M — down 11% from $41M a quarter earlier.

Sellers outnumbered buyers: 18 funds closed out of OSIR and 8 opened new positions — a net loss of 10 holders — while 17 trimmed existing stakes and 22 added.

The largest buyer was Deutsche Bank, adding an estimated $666K. The largest seller was Two Sigma Investments, exiting entirely with an estimated $446K sold.

  • 68 institutional investors held Osiris Therapeutics, Inc. Common Stock (OSIR) as of Q2 2016, down from 80 in Q1 2016.
  • Funds reported $36.2M of Osiris Therapeutics, Inc. Common Stock stock for Q2 2016, down 11% quarter-over-quarter.
  • 8 funds opened new Osiris Therapeutics, Inc. Common Stock positions in Q2 2016 and 18 closed out, a net change of -10 holders.
  • The largest Osiris Therapeutics, Inc. Common Stock buyer in Q2 2016 was Deutsche Bank, an estimated $666K added.
  • The largest Osiris Therapeutics, Inc. Common Stock seller in Q2 2016 was Two Sigma Investments, an estimated $446K sold.

Based on aggregated 13F filings for Q2 2016.